COACT Study: CGRPmAbs + OnabotulinumtoxinA Assessment of Chronic Migraine Treatments Study
Condition: Chronic Migraine, Headache Intervention: Drug: Combination of Botox + CGRPmAb (Fremanezumab 225mg/1.5mL) Sponsor: Chicago Headache Center & Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2023 Category: Research Source Type: clinical trials
Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease
Conditions: Buerger Disease; Raynaud Syndrome Intervention: Drug: BOTOX INJECTION Sponsor: University Hospital, Toulouse Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2023 Category: Research Source Type: clinical trials